Journal of Capital Medical University ›› 2017, Vol. 38 ›› Issue (6): 879-883.doi: 10.3969/j.issn.1006-7795.2017.06.020

Previous Articles     Next Articles

Decreased α-synuclein phosphorylation and oligomerization in the plasma of patients with type 2 diabetes

Zheng Songyang1,2, Li Xin1,2,3,4, Yang Weiwei1,2,3,4, Li Xuran1,2, Li Xuying1,2, Yu Wenjiao1,2, Yu Shun1,2,3,4   

  1. 1. Department of Neurobiology, Xuanwu Hospital, Capital Medical University, Beijing Institute of Geriatrics, Beijing 100053, China;
    2. Clinical Center for Parkinson's Disease, Capital Medical University, Beijing 100053, China;
    3. Beijing Key Laboratory for Parkinson's Disease and Key Laboratory of Neurodegenerative Diseases, Ministry of Education, Beijing 100053, China;
    4. National Clinical Research Center for Geriatric Disorders, Beijing 100053, China
  • Received:2017-10-23 Online:2017-11-21 Published:2017-12-16
  • Supported by:
    This study was supported by National Natural Science Foundation of China (81371200, 81071014, 81401042); Beijing Municipal Administration of Hospitals' Mission Plan (SML20150803); Beijing Municipal Science & Technology Commission (Z161100005116011,Z171100000117013); Beijing Municipal commission of Health and Family Planning (PXM2017_026283_000002).

Abstract: Objective To investigate the effect of the plasma of patients with type 2 diabetes (T2D) patient on the formation of oligomeric and phosphorylated α-synuclein (α-Syn).Methods A total of 70 hospitalized patients with T2D and 70 age-and sex-matched healthy control subjects were recruited. Blood plasmas were collected and recombinant human α-Syn was incubated with the plasma. ELISA was used to measure the levels of oligomeric and phosphorylated α-syn formed in the plasma. Results The levels of oligomeric and phosphorylated α-syn in the plasma of T2D patients were significantly lower than those in the plasma of healthy controls (P<0.05), which was positively correlated with age.Conclusion Compared with control plasma, the plasma from T2D patients decreases α-syn oligomerization and phosphorylation in an age-dependent manner.

Key words: α-synuclein, type 2 diabetes, plasma, phosphorylation, oligomerization

CLC Number: